抑郁和肥胖对抑制控制神经相关的附加效应
Lisa-Katrin Kaufmann1, Emma Custers2, Debby Vreeken2
1Donders Institute for Brain Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands.
Journal of affective disorders
|July 3, 2024
概括
同时的抑郁和肥胖会通过改变大脑连接来恶化抑制控制. 系统性炎症可能在这种综合效应中发挥作用,影响神经认知功能.
科学领域:
- 神经科学是一个神经科学.
- 认知科学 认知科学
- 精神病学是一个精神病学.
背景情况:
- 抑郁症和肥胖症与抑制性控制受损有关.
- 同时出现的抑郁症和肥胖症对神经认知性能产生了加剧的影响.
- 系统性炎症是影响神经认知缺陷的潜在因素.
研究的目的:
- 研究抑郁症和肥胖对抑制控制的综合影响背后的神经机制.
- 检查系统性炎症作为连接这些疾病和神经认知障碍的潜在途径的作用.
主要方法:
- fMRI Stroop任务用于评估64名肥胖和不同抑郁情绪的个体的抑制控制.
- 在任务期间探测了神经激活和连接.
- 研究了神经反应改变和全身炎症标志物之间的关联.
主要成果:
- 同时的抑郁和肥胖与补充运动区域和前骨之间的功能连接增加,以及下部和下部环之间的功能连接增加有关.
- 探索性分析表明,炎症标志物 (勒,IL-6,IL-8,CCL-3) 与抑郁症和肥胖对功能连接性改变的附加效应之间的相关性.
结论:
- 研究结果表明,增加的神经交叉声会导致抑郁症和肥胖症同时发生的个体的抑制控制受损.
- 结果支持一种模型,即同时出现抑郁症和肥胖症对神经认知功能产生了附加的有害影响.
- 炎症可能在这些神经认知变化中发挥重要作用.
相关概念视频
Attention-Deficit/Hyperactivity Disorder
54
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
54
Depressive Disorders: Etiology
63
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
63
Antidepressant Drugs: MAOIs and Other Agents
215
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
215
Depression: Overview
237
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
237


